Dimerix Limited (ASX: DXB, "Dimerix") a clinical-stage biopharmaceutical company developing kidney disease treatments, is pleased to announce that it has acquired DMX-652 for all indications from ...
Highlights Dimerix acquires Phase 2-ready asset, DMX-652 - with potential for rapid advancement into a Phase 2 clinical study under an open US Investigational New ...
It's been a journey for Arieauna Johnson as her mother, Melissa, battles kidney failure. "It’s been difficult. That’s why ...
From organizing the local bingo in Richer to supporting rural food banks and helping students pursue their ...
Learn more about whether ACADIA Pharmaceuticals Inc. or CareDx, Inc. is a better investment based on AAII's A+ Investor ...
Unless otherwise noted, all growth rates in this Release refer to same period in prior year. 2. Please see detailed guidance assumptions on page 7. 3. USD millions unless indicated otherwise. Novartis ...
Discover the 12 everyday mistakes causing energy loss after 50 and what actually helps. The post 12 Everyday Habits That Are ...
Dimerix expands kidney pipeline with DMX-652 acquisition; Phase 2-ready AKI therapy targets US$3.5b market, upfront US$5m ...
Background Circulatory collapse at hospital arrival represents one of the most severe clinical presentations of ST-segment ...
For decades, people have been told they should drink eight glasses of water every day. But kidney specialists say that ...